Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F. Ambinder

Showing results (121-130 of 218) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|March 8, 2007
Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignanciesJianming Ying, Zifen Gao, Hongyu Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2011
B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphomaElizabeth Crabb Breen, Shehnaz K Hussain, Larry Magpantay, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2013
Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma riskElena Vendrame, Shehnaz K Hussain, Elizabeth Crabb Breen, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 11, 2018
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)Juan C Ramos, Joseph A Sparano, Michelle A Rudek, et al.
Current HIV Research|October 20, 2018
Prevalence of HIV in Patients with Malignancy and of Malignancy in HIV Patients in a Tertiary Care Center from North IndiaSanjeev Sinha, Ashish Agarwal, Kartik Gupta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2019
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic LeukemiaSuman Paul, Hua-Ling Tsai, Patrick Lowery, et al.
Theranostics|January 2, 2018
Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomasLili Li, Juan Xu, Guohua Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi SarcomaErin G Reid, Kelly Shimabukuro, Page Moore, et al.
AIDS (London, England)|March 20, 2010
Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort studyHui-Lee Wong, Elizabeth C Breen, Ruth M Pfeiffer, et al.
Theranostics|February 24, 2022
Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: ErratumLili Li, Juan Xu, Guohua Qiu, et al.
Pageof 22

Showing results (121-130 of 218) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|March 8, 2007
Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignanciesJianming Ying, Zifen Gao, Hongyu Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2011
B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphomaElizabeth Crabb Breen, Shehnaz K Hussain, Larry Magpantay, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2013
Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma riskElena Vendrame, Shehnaz K Hussain, Elizabeth Crabb Breen, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 11, 2018
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)Juan C Ramos, Joseph A Sparano, Michelle A Rudek, et al.
Current HIV Research|October 20, 2018
Prevalence of HIV in Patients with Malignancy and of Malignancy in HIV Patients in a Tertiary Care Center from North IndiaSanjeev Sinha, Ashish Agarwal, Kartik Gupta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2019
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic LeukemiaSuman Paul, Hua-Ling Tsai, Patrick Lowery, et al.
Theranostics|January 2, 2018
Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomasLili Li, Juan Xu, Guohua Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi SarcomaErin G Reid, Kelly Shimabukuro, Page Moore, et al.
AIDS (London, England)|March 20, 2010
Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort studyHui-Lee Wong, Elizabeth C Breen, Ruth M Pfeiffer, et al.
Theranostics|February 24, 2022
Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: ErratumLili Li, Juan Xu, Guohua Qiu, et al.
Pageof 22